(Q30660487)

26 June 2017

MR in phenylketonuria-related brain lesions (English)

1 reference

26 June 2017

1 reference

Dezortová M

1

1 reference

26 June 2017

Hájek M

2

1 reference

26 June 2017

Tintera J

3

1 reference

26 June 2017

Hejcmanová L

4

1 reference

26 June 2017

Syková E

5

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

26 June 2017

1 reference

26 June 2017

42

1 reference

26 June 2017

5

1 reference

26 June 2017

459-466

1 reference

White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings.

26 June 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

Absolute quantitative proton NMR spectroscopy based on the amplitude of the local water suppression pulse. Quantification of brain water and metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

Localized brain proton NMR spectroscopy in young adult phenylketonuria patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

Near-microscopic magnetic resonance imaging of the brains of phenylalanine hydroxylase-deficient mice, normal littermates, and of normal BALB/c mice at 9.4 Tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

Golgi-Kopsch silver study of the brain of a patient with untreated phenylketonuria, seizures, and cortical blindness

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

Neuropathology of phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

Phenylketonuria: MR imaging of the brain with clinical correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

Retarded development of neurons and oligodendroglia in rat forebrain produced by hyperphenylalaninemia results in permanent deficits in myelin despite long recovery periods

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

Phenylalanine and phenylacetate adversely affect developing mammalian brain neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

Brain MRI changes in phenylketonuria. Associations with dietary status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

Different degrees of white matter abnormalities in untreated phenylketonurics: findings in magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

Brain damage and recovery in hyperphenylalaninemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

7 January 2021

Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

7 January 2021

Decreasing choline signal--a marker of phenylketonuria?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

7 January 2021

Brain development in experimental hyperphenylalaninaemia: disturbed proliferation and reduced cell numbers in the cerebellum

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

7 January 2021

Identification and quantitation of phenylalanine in the brain of patients with phenylketonuria by means of localized in vivo 1H magnetic-resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

7 January 2021

Neuroradiological (MRI) abnormalities in phenylketonuric subjects: clinical and biochemical correlations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

7 January 2021

In-vivo NMR spectroscopy in patients with phenylketonuria: changes of cerebral phenylalanine levels under dietary treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

7 January 2021

In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

7 January 2021

On the Possible Mechanism of Phenylacetate Neurotoxicity: Inhibition of Choline Acetyltransferase by Phenylacetyl-CoA

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

7 January 2021

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

7 January 2021

Evolution of anisotropic diffusion in the developing rat corpus callosum.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0455.2001.420505.X

7 January 2021

10.1034/J.1600-0455.2001.420505.X

Identifiers

DOI

1 reference

release_kg632vhd45hr3fjz5oktuxm374

26 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kg632vhd45hr3fjz5oktuxm374

24 November 2022

mapped directly with Wikidata item

1 reference